跳转至内容
Merck
CN

主要文件

查看所有文档

SML4113

OGT2115

≥97% (HPLC)

别名:

2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propen-1-yl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid, 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid, OGT 2115, OGT-2115

登录 查看组织和合同定价。

选择规格

变更视图

关于此项目

经验公式（希尔记法）:
C24H16BrFN2O4
化学文摘社编号:
853929-59-6
分子量:
495.30
MDL number:
MFCD12828743
NACRES:
NA.28
Assay:
≥97% (HPLC)
Form:
powder
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Segment

100

assay

≥97% (HPLC)

form

powder

color

white to beige

solubility

soluble (DMSO:0.1M NaOH (95:5), 1.0 mg/mL, clear, warmed, may need to sonicate.)

storage temp.

-10 to -25°C

Biochem/physiol Actions

Heparanase (HPSE) inhibitor with anti-angiogenesis potency and no inhibition of major human cytochrome P450 enzymes.

OGT 2115 is a heparanase (HPSE) inhibitor (IC50 = 0.4 μM) with anti-angiogenesis potency in human endothelial cell cultures (tubule formation IC50 = 1 μM) and no inhibition of major human cytochrome P450 enzymes (Cyp3A4 & Cyp2C9 IC50 > 30 μM).

pictograms

Skull and crossbones
GHS06

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库